Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): Third round

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Stegeman, Inge ^a   de Wijkerslooth, Thomas R ^a   Mallant Hent, Rosalie C ^a,b   de Groot, Karin ^a   Stroobants, An K ^a   Fockens, Paul ^a   Mundt, Marco ^b   Bossuyt, Patrick M M ^a   Dekker, Evelien ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Flevohospital ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC VALUE; FECAL IMMUNOCHEMICAL TEST; HEALTH PROGRAM; IMMUNOCHEMISTRY; NETHERLANDS; PATIENT PARTICIPATION; STUDY DESIGN;

AGED; COHORT STUDIES; COLORECTAL NEOPLASMS; CONSUMER PARTICIPATION; DATABASES, FACTUAL; DIAGNOSTIC TESTS, ROUTINE; EARLY DETECTION OF CANCER; FECES; FEMALE; HEALTH PLAN IMPLEMENTATION; HUMANS; IMMUNOCHEMISTRY; MALE; MIDDLE AGED; NETHERLANDS; OCCULT BLOOD; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 84862299967     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-73     Document Type: Article

References (19)

1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010, 46:765-781. 10.1016/j.ejca.2009.12.014, 20116997.
2. SEER Stat Fact Sheet; colon and rectum National Cancer Institute, http://seer cancer gov/statfacts/html/colorecthtml2011.
3. Gondos A, Bray F, Brewster DH, Coebergh JW, Hakulinen T, Janssen-Heijnen ML, et al. Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries. Eur J Cancer 2008, 44:1463-1475. 10.1016/j.ejca.2008.03.010, 18455387.
4. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993, 329:1977-1981. 10.1056/NEJM199312303292701, 8247072.
5. Hardcastle JD, Thomas WM, Chamberlain J, Pye G, Sheffield J, James PD, et al. Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet 1989, 1:1160-1164.
6. Wilson JM, Jungner YG. Principles and practice of mass screening for disease. Bol Oficina Sanit Panam 1968, 65:281-393.
7. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American cancer society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008, 134:1570-1595. 10.1053/j.gastro.2008.02.002, 18384785.
8. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008, 103:1541-1549. 10.1111/j.1572-0241.2008.01875.x, 18479499.
9. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010, 375:1624-1633. 10.1016/S0140-6736(10)60551-X, 20430429.
10. von Karsa L, Anttila A, Ronco G, Ponti A, Malila N, Arbyn M, et al. Cancer Screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening http://ec europe eu/health/ph_determinants/genetics/documents/cancer_screeningpdf2009.
11. van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008, 135:82-90. 10.1053/j.gastro.2008.03.040, 18482589.
12. Hol L, Van Leerdam ME, van BM, Van Vuuren AJ, Van DH, Reijerink JC, et al. Screening For Colorectal Cancer; Randomised Trial Comparing Guaiac-Based And Immunochemical Faecal Occult Blood Testing And Flexible Sigmoidoscopy. Gut 2009, 9:28-35.
13. Denters MJ, Deutekom M, Fockens P, Bossuyt PM, Dekker E. Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands. BMC Gastroenterol 2009, 9:28. 10.1186/1471-230X-9-28, 2680893, 19393087.
14. Denters MJ, Deutekom M, Bossuyt PM, Stroobants AK, Fockens P, Dekker E. Lower Risk of Advanced Neoplasia Among Patients with a Previous Negative Result from a Fecal Test for Colorectal Cancer. Gastroenterology 2011, 142:497-504.
15. Steele RJ, McClements PL, Libby G, Black R, Morton C, Birrell J, et al. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut 2009, 58:530-535. 10.1136/gut.2008.162883, 19036949.
16. Rex DK, Petrini JL, Baron TH, Chak A, Cohen J, Deal SE, et al. Quality indicators for colonoscopy. Gastrointest Endosc 2006, 63:S16-S28. 10.1016/j.gie.2006.02.021, 16564908.
17. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000, 47:251-255. 10.1136/gut.47.2.251, 1728018, 10896917.
18. Nagengast FM, Kaandorp CJ. Revised CBO guideline 'Follow-up after polypectomy'. Ned Tijdschr Geneeskd 2001, 145:2022-2025.
19. Integraal Kanker Centrum 2012, Ref Type: Online Source, Integraal Kanker Centrum.